Asian Oncol Nurs.  2018 Dec;18(4):241-246. 10.5388/aon.2018.18.4.241.

Factors Affecting Cognitive Function in Patients with Stomach Cancer

• Yu YJ
• Ahn SH
• Cho YA
• Ryu E
• Kim EJ

• KMID: 2431007
• DOI: http://doi.org/10.5388/aon.2018.18.4.241

Abstract

PURPOSE
This study aimed to identify factors affecting cognitive function in stomach cancer patients.
METHODS
This was a cross-sectional study designed to obtain data from stomach cancer patients. The Global Assessment of Recent Stress, Hospital Anxiety-Depression Scale, Distress Thermometer, Korean version of the Montreal Cognitive Assessment, and electronic medical records were used to assess stress, anxiety, depression, psychological distress, and cognitive function, respectively.
RESULTS
Among 182 total participants, there were statistically significant differences in sex between the group of patients who received chemotherapy and those who did not (χ2=5.32, p=.029). There were statistically significant differences in stress and cognitive function between the two groups. The factors affecting cognitive function in stomach cancer patients included distress, stress, anxiety, and depression.
CONCLUSION
Cognitive function should be examined with consideration of the psychological distress, stress, anxiety, and depression in patients with stomach cancer. Moreover, an improved program to manage cognitive function is needed, which includes mediation between psychological and physiological factors including stress, anxiety, and cognitive level.

Keyword

Drug Therapy; Stomach Neoplasms; Cognitive Dysfunction; Psychological Stress

MeSH Terms

Anxiety
Cognition*
Cross-Sectional Studies
Depression
Drug Therapy
Electronic Health Records
Humans
Negotiating
Stomach Neoplasms*
Stomach*
Stress, Psychological
Thermometers

Reference

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136:E359–E386.

2. Jung KW, Won YJ, Kong HJ, Lee ES, Community of. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018; 50:303–316.

3. Kim JH. Influencing factors on depression in stomach cancer patients receiving chemotherapy. Korean J Adult Nurs. 2012; 24:588–596.

4. Shim EJ, Shin YW, Jeon HJ, Hahm BJ. Distress and its correlates in Korean cancer patients: pilot use of the distress thermometer and the problem list. Psychooncology. 2008; 17:548–555.

5. Gehring K, Roukema JA, Sitskoorn MM. Review of recent studies on interventions for cognitive deficits in patients with cancer. Expert Rev Anticancer Ther. 2012; 12:255–269.

6. Hess LM, Insel KC. Chemotherapy-related change in cognitive function: a conceptual model. Oncol Nurs Forum. 2007; 34:981–994.

7. Yi MS, Kim JH, Park EY, Kim JN, Yu ES. Focus group study on psychosocial distress of cancer patients. J Korean Acad Adult Nurs. 2010; 22:19–30.

8. Chida Y, Hamer M, Wardle J, Steptoe A. Do stress-related psychosocial factors contribute to cancer incidence and survival? Nat Clin Pract Oncol. 2008; 5:466–475.

9. Wood DE. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening. Thorac Surg Clin. 2015; 25:185–197.

10. Koh KB. Stress perception of patients with psychosomatic disorders. J Korean Neuropsychiatr Assoc. 1988; 27:514–524.

11. Koh KB, Park JK. Validity and reliability of the Korean version of the global assessment of recent stress scale. Korean J Psychosom Med. 2000; 8:201–211.

12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67:361–370.

13. Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: a comparison of normal, depressed and anxious groups. J Korean Neuropsychiatr Assoc. 1999; 38:289–296.

14. Holland JC. Update: NCCN practice guidelines for the management of psychosocial distress. Oncology. 1999; 13:459–507.

15. Lee JY, Lee DW, Cho SJ, Na DL, Jeon HJ, Kim SK, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. J Geriatr Psychiatry Neurol. 2008; 21:104–110.

16. Jeon MK, Park GJ. Development of a self-care performance scale for patients with stomach cancer after gastrectomy. Asian Oncol Nurs. 2016; 16:67–74.

17. Lee KE, Son YG. Research trends of quality of life after gastrectomy among gastric cancer patients in Korea. Asian Oncol Nurs. 2016; 16:59–66.

18. Krynetskiy E, Krynetskaia N, Rihawi D, Wieczerzak K, Ciummo V, Walker E. Establishing a model for assessing DNA damage in murine brain cells as a molecular marker of chemotherapy-associated cognitive impairment. Life Sci. 2013; 93:605–610.

19. Jansen CE, Cooper BA, Dodd MJ, Miaskowski CA. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support Care Cancer. 2011; 19:1647–1656.

20. Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS, et al. Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. 2008; 110:143–152.

21. Fulcher CD, Badter T, Gunter AK, Marrs JA, Reese JM. Putting evidence into practice: interventions for depression. Clin J Oncol Nurs. 2008; 12:131–140.

22. Jo KS, Ban JY, Yoon JY, Kook SH, Yoon HS, Yoo YS. Quality of life in patients with multiple myeloma. Korean J Adult Nurs. 2016; 28:314–322.

23. Hoffman AJ, von Eye A, Gift AG, Given BA, Given CW, Rothert M. The development and testing of an instrument for perceived self-efficacy for fatigue self-management. Cancer Nurs. 2011; 34:167–175.

24. Kwon EJ, Yi M. Distress and quality of life in breast cancer survivors in Korea. Asian Oncol Nurs. 2012; 12:289–296.

25. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A meta-analysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005; 104:2222–2233.

26. Oh PJ, Kim JH. Chemotherapy-related cognitive impairment and quality of life in people with colon cancer: the mediating effect of psychological distress. J Korean Acad Nurs. 2016; 46:19–28.

27. Choi CH, Park S, Park HJ, Cho Y, Sohn BK, Lee JY. Study on cognitive reserve in Korea using Korean version of Cognitive Reserve Index Questionnaire. J Korean Neuropsychiatr Assoc. 2016; 55:256–263.

28. Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treat Rev. 2012; 38:926–934.